In breast cancer cells treated with atorvastatin, RT-qRCR was used to analyze the mRNA expression level of RhoB and PTEN, and Western blot was used to detect the protein expression level of RhoB or PTEN/AKT signaling pathway-related molecules-PTEN, AKT, and p-AKT. Here, AKT1 is linked to breast carcinoma.